Literature DB >> 22009621

Aortic stiffness, blood pressure and renal dysfunction.

Davide Grassi1, Claudio Ferri.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22009621     DOI： 10.1007/s11739-011-0678-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  27 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

2.  Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Authors:  Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

Review 3.  Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis.

Authors:  Davide Grassi; Giovambattista Desideri; Claudio Ferri
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

4.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

5.  Mild renal dysfunction and renal vascular resistance in primary hypertension.

Authors:  Lorenzo E Derchi; Giovanna Leoncini; Denise Parodi; Francesca Viazzi; Carlo Martinoli; Elena Ratto; Simone Vettoretti; Valentina Vaccaro; Valeria Falqui; Cinzia Tomolillo; Giacomo Deferrari; Roberto Pontremoli
Journal:  Am J Hypertens       Date:  2005-07       Impact factor: 2.689

6.  Central pulse pressure and mortality in end-stage renal disease.

Authors:  Michel E Safar; Jacques Blacher; Bruno Pannier; Alain P Guerin; Sylvain J Marchais; Pierre-Marie Guyonvarc'h; Gérard M London
Journal:  Hypertension       Date:  2002-03-01       Impact factor: 10.190

7.  Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients.

Authors:  Bruno Pannier; Alain P Guérin; Sylvain J Marchais; Michel E Safar; Gérard M London
Journal:  Hypertension       Date:  2005-03-07       Impact factor: 10.190

8.  Arterial stiffness and cardiovascular events: the Framingham Heart Study.

Authors:  Gary F Mitchell; Shih-Jen Hwang; Ramachandran S Vasan; Martin G Larson; Michael J Pencina; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

Review 9.  Arterial structure and function in end-stage renal disease.

Authors:  Alain P Guérin; Bruno Pannier; Sylvain J Marchais; Gérard M London
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

Review 10.  Mechanical factors in arterial aging: a clinical perspective.

Authors:  Michael F O'Rourke; Junichiro Hashimoto
Journal:  J Am Coll Cardiol       Date:  2007-06-18       Impact factor: 24.094
View more
  3 in total

Review 1.  Arterial Stiffness: A Nexus between Cardiac and Renal Disease.

Authors:  Guanghong Jia; Annayya R Aroor; James R Sowers
Journal:  Cardiorenal Med       Date:  2014-03-14       Impact factor: 2.041

2.  Black tea lowers blood pressure and wave reflections in fasted and postprandial conditions in hypertensive patients: a randomised study.

Authors:  Davide Grassi; Richard Draijer; Giovambattista Desideri; Theo Mulder; Claudio Ferri
Journal:  Nutrients       Date:  2015-02-04       Impact factor: 5.717

3.  Arterial stiffness acute changes following aerobic exercise in males with and without hypertension.

Authors:  Yiran Zang; Xiong Ding; Mao Xiang Zhao; Xiaoling Zhang; Li Zhang; Shouling Wu; Lixia Sun
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-03-14       Impact factor: 3.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.